Journal of Clinical & Experimental OncologyISSN: 2324-9110

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report, J Clin Exp Oncol Vol: 6 Issue: 2

Chemoradiotherapy In Locally Invasive Parathyroid Cancer

Sema Yilmaz Rakici1*, Cemil Bilir2, Gülnihal Tufan2 and ZihniAcar Yazici3
1Department of Radiation Oncology, Recep Tayyip Erdogan University Medical School, 53100, Rize, Turkey
2Department of Medical Oncology, Recep Tayyip Erdogan University Medical School, 53100, Rize, Turkey
3Department of Microbiology, Recep Tayyip Erdogan University Medical School, 53100, Rize, Turkey
Corresponding author : Sema Yilmaz Rakici
Department of Radiation Oncology, Recep Tayyip Erdogan University Medical School, 53100, Rize, Turkey
Tel: +90 505 4028302
E-mail: [email protected]
Received: January 27, 2017 Accepted: February 16, 2017 Published: February 23, 2017
Citation: Rakici SY, Bilir C, Tufan G, Yazici Z (2017) Chemoradiotherapy In Locally Invasive Parathyroid Cancer. J Clin Exp Oncol 6:2. doi: 10.4172/2324-9110.1000179

Abstract

Parathyroid cancers (PTC) are very rare and have a poor prognosis. A 48 year old case with locally invasive PTC that was positive for close surgical removal margin was treated with chemo radiotherapy after surgery. Even though this required bimodal chemo and radio adjuvant therapy, the patient was treated by chemo radiotherapy with some modifications, including oral administration of capestabine. These treatments were well tolerated with minimal side effects, which have proven to be very effective in freeing the patient from the invasive tumor for the following twenty six months of monitoring. This treatment method could be adopted in place of the widely preferred surgical therapy. We believe that this case report will guide future studies concerning with similar cases.

Keywords: Parathyroid carcinoma; Chemo radiotherapy; Low toxicity; Positive surgical margin

Track Your Manuscript

Share This Page

Media Partners